InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（15 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
15
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Hill Emily Luisa, Directrice Financière. Director active across 2 companies, notably PTC Therapeutics, INC.. In total, 21 disclosures have been logged. Split: 0 buy · 15 sells. Total volume traded: €1.1m. History available since 4 January 2022. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hill Emily Luisa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
9,256 股@ US$14.280.0097% mcap29.6% 占其流量Common StockSEC:0001104659-26-098868:0
11,448 股@ US$12.970.011% mcap47.3% 占其流量Common StockSEC:0001104659-26-095008:0
50,000 股0Common StockSEC:0001104659-26-040566:0
60,000 股0Common StockSEC:0001104659-25-123285:0
9,154 股@ US$5.3729.5% 占其流量Common StockSEC:0001104659-25-080403:0
2,535 股@ US$8.0517.9% 占其流量Common StockSEC:0001104659-25-052142:0
45,000 股0Common StockSEC:0001104659-25-031829:0
8,938 股@ US$10.1882.1% 占其流量Common StockSEC:0001104659-24-090980:0
26,665 股0Common StockSEC:0001104659-24-043253:0
83,330 股0Common StockSEC:0001104659-23-102485:0
7,363 股@ US$45.0039.3% 占其流量Common StockSEC:0001415889-23-005564:0
575 股@ US$45.6283.1% 占其流量Common StockSEC:0001415889-23-001798:0
223 股@ US$47.45131.2% 占其流量Common StockSEC:0001415889-23-001459:0
497 股@ US$42.93292.5% 占其流量Common StockSEC:0001415889-23-000880:0
758 股@ US$41.65623.8% 占其流量Common StockSEC:0001415889-23-000838:0
19,500 股0Common StockSEC:0001415889-23-000691:0
7,910 股@ US$37.77837.5% 占其流量Common StockSEC:0001415889-22-003564:0
553 股@ US$40.0022.7% 占其流量Common StockSEC:0001179110-22-000837:0
211 股@ US$39.3141.0% 占其流量Common StockSEC:0001179110-22-000629:0
800 股@ US$38.5253.8% 占其流量Common StockSEC:0001179110-22-000398:0
173 股@ US$41.1620.9% 占其流量Common StockSEC:0001179110-22-000303:0
21 条申报中的 21 条
About Hill Emily Luisa
Emily Luisa Hill is Chief Financial Officer and is associated with PTC Therapeutics, INC. and Replimune Group, Inc. She has filed 19 forms in total, and across the 19 recent filings sampled between 2022-01-06 and 2026-04-07, the transactions shown are sales for EUR 863692, with notable filings at PTC Therapeutics, INC. and Replimune Group, Inc.
